These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 28065636)

  • 1. Neuroprotection and neurotoxicity in the developing brain: an update on the effects of dexmedetomidine and xenon.
    Alam A; Suen KC; Hana Z; Sanders RD; Maze M; Ma D
    Neurotoxicol Teratol; 2017; 60():102-116. PubMed ID: 28065636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective interaction produced by xenon and dexmedetomidine on in vitro and in vivo neuronal injury models.
    Rajakumaraswamy N; Ma D; Hossain M; Sanders RD; Franks NP; Maze M
    Neurosci Lett; 2006 Dec; 409(2):128-33. PubMed ID: 17052852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroprotective Properties of Xenon.
    Maze M; Laitio T
    Mol Neurobiol; 2020 Jan; 57(1):118-124. PubMed ID: 31758401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dexmedetomidine pretreatment attenuates propofol‑induced neurotoxicity in neuronal cultures from the rat hippocampus.
    Wei Y; Hu J; Liang Y; Zhong Y; He D; Qin Y; Li L; Chen J; Xiao Q; Xie Y
    Mol Med Rep; 2016 Oct; 14(4):3413-20. PubMed ID: 27571870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dexmedetomidine mitigates sevoflurane-induced cell cycle arrest in hippocampus.
    Bo LJ; Yu PX; Zhang FZ; Dong ZM
    J Anesth; 2018 Oct; 32(5):717-724. PubMed ID: 30128750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protecting the Brain With Xenon Anesthesia for Neurosurgical Procedures.
    Rylova A; Maze M
    J Neurosurg Anesthesiol; 2019 Jan; 31(1):18-29. PubMed ID: 29470316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of Anesthesia on the Developing Brain: Infant and Fetus.
    Andropoulos DB
    Fetal Diagn Ther; 2018; 43(1):1-11. PubMed ID: 28586779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review and narrative synthesis on the histological and neurobehavioral long-term effects of dexmedetomidine.
    van Hoorn CE; Hoeks SE; Essink H; Tibboel D; de Graaff JC
    Paediatr Anaesth; 2019 Feb; 29(2):125-136. PubMed ID: 30475445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xenon provides short-term neuroprotection in neonatal rats when administered after hypoxia-ischemia.
    Dingley J; Tooley J; Porter H; Thoresen M
    Stroke; 2006 Feb; 37(2):501-6. PubMed ID: 16373643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [How xenon works: neuro and cardioprotection mechanisms].
    Morais R; Andrade L; Lourenço A; Tavares J
    Acta Med Port; 2014; 27(2):259-65. PubMed ID: 24813496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine-mediated neuroprotection against sevoflurane-induced neurotoxicity extends to several brain regions in neonatal rats.
    Perez-Zoghbi JF; Zhu W; Grafe MR; Brambrink AM
    Br J Anaesth; 2017 Sep; 119(3):506-516. PubMed ID: 28969317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of dexmedetomidine on sevoflurane-induced neurodegeneration in neonatal rats.
    Lee JR; Joseph B; Hofacer RD; Upton B; Lee SY; Ewing L; Zhang B; Danzer SC; Loepke AW
    Br J Anaesth; 2021 May; 126(5):1009-1021. PubMed ID: 33722372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms transducing the anesthetic, analgesic, and organ-protective actions of xenon.
    Preckel B; Weber NC; Sanders RD; Maze M; Schlack W
    Anesthesiology; 2006 Jul; 105(1):187-97. PubMed ID: 16810011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain protection by anesthetic agents.
    Koerner IP; Brambrink AM
    Curr Opin Anaesthesiol; 2006 Oct; 19(5):481-6. PubMed ID: 16960478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurotoxicity of sub-anesthetic doses of sevoflurane and dexmedetomidine co-administration in neonatal rats.
    Perez-Zoghbi JF; Zhu W; Neudecker V; Grafe MR; Brambrink AM
    Neurotoxicology; 2020 Jul; 79():75-83. PubMed ID: 32387222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical neuroprotective actions of xenon and possible implications for human therapeutics: a narrative review.
    Maze M
    Can J Anaesth; 2016 Feb; 63(2):212-26. PubMed ID: 26507536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection against traumatic brain injury by xenon, but not argon, is mediated by inhibition at the N-methyl-D-aspartate receptor glycine site.
    Harris K; Armstrong SP; Campos-Pires R; Kiru L; Franks NP; Dickinson R
    Anesthesiology; 2013 Nov; 119(5):1137-48. PubMed ID: 23867231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexmedetomidine: new insights.
    Mantz J; Josserand J; Hamada S
    Eur J Anaesthesiol; 2011 Jan; 28(1):3-6. PubMed ID: 20881501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentially neuroprotective and therapeutic properties of nitrous oxide and xenon.
    Abraini JH; David HN; Lemaire M
    Ann N Y Acad Sci; 2005 Aug; 1053():289-300. PubMed ID: 16179534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neither xenon nor fentanyl induces neuroapoptosis in the newborn pig brain.
    Sabir H; Bishop S; Cohen N; Maes E; Liu X; Dingley J; Thoresen M
    Anesthesiology; 2013 Aug; 119(2):345-57. PubMed ID: 23591070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.